While management highlighted strong revenue and earnings growth, Glastra said fourth-quarter margins and cash flow came in below expectations set on the third-quarter call due to a deliberate operational choice. As the quarter progressed, Novanta prioritized customer deliveries over the pace of regional manufacturing transfers , which led to temporary dual running costs and elevated inventory.By end market, Buckley said medical represented 53% of total sales in both the quarter and the full year, with advan ...

Strategic Performance Drivers - Achieved record fourth-quarter revenue and a return to organic growth, driven by a 25% surge in bookings across all business units [4] - Attributed margin and cash flow pressure to a deliberate strategic decision to prioritize customer deliveries over the pace of regional manufacturing transfers [4] - Capitalized on AI-driven tailwinds in robotics, specifically as the sole-source supplier for precision drilling of high-density GPU boards [4] - Expanded the medical technology portfolio to 53% of total sales, leveraging next-generation insufflation platforms to drive double-digit growth in consumables [4] - Utilized the Novanta Growth System (NGS) to embed continuous improvement and operational efficiency as a competitive differentiator for OEM partnerships [4] 2026 Outlook and Strategic Priorities - Projecting mid-single-digit organic growth for 2026, supported by a record backlog and accelerating momentum in semiconductor and robotic surgery markets [4] - Anticipating 100 basis points of gross margin expansion as regional manufacturing transfers are scheduled for completion by the end of the second quarter [4] - Planning to deploy nearly $1.5 billion in acquisition capacity toward larger opportunities in medical technologies, bioprocessing, and embedded software [4] - Expecting a significant rebound in operating cash flow, forecasted at $145 million to $185 million, following the drawdown of temporary inventory buffers [4] - Integrating artificial intelligence tools across R&D and back-office processes to accelerate productivity goals and innovation cycles [4] Operational Context and Risk Factors - Identified a temporary 100 basis point headwind to gross margin due to dual running costs during the final phases of site regionalization [4] - Noted a $0.22 to $0.24 EPS headwind from the November equity fundraise, which remains a temporary drag until capital is deployed for M&A [4] - Flagged a one-time $0.14 EPS impact in 2026 related to a 2025 all-employee equity grant that replaced the standard cash bonus program [4] - Highlighted the Keyon acquisition's outperformance, which is serving as a strategic entry point for RFID and data solutions in hospital environments [4]

Novanta (NasdaqGS:NOVT) Q4 2025 Earnings call February 24, 2026 08:00 AM ET Company ParticipantsMatthijs Glastra - Chair and CEORay Nash - Corporate Finance LeaderRobert Buckley - CFOConference Call ParticipantsBrian Drab - Equity Research AnalystLee Jagoda - Equity Research AnalystRob Mason - Managing Director and Senior Research AnalystOperatorAlso note, today's event is being recorded. At this time, I'd like to turn the conference call over to Ray Nash, Corporate Finance Leader for Novanta. Please go ahe ...

Novanta (NasdaqGS:NOVT) Q4 2025 Earnings call February 24, 2026 08:00 AM ET Company ParticipantsMatthijs Glastra - Chair and CEORay Nash - Corporate Finance LeaderRobert Buckley - CFOConference Call ParticipantsBrian Drab - Equity Research AnalystLee Jagoda - Equity Research AnalystRob Mason - Managing Director and Senior Research AnalystOperatorAlso note, today's event is being recorded. At this time, I'd like to turn the conference call over to Ray Nash, Corporate Finance Leader for Novanta. Please go ahe ...

Novanta (NasdaqGS:NOVT) Q4 2025 Earnings call February 24, 2026 08:00 AM ET Speaker3Also note, today's event is being recorded. At this time, I'd like to turn the conference call over to Ray Nash, Corporate Finance Leader for Novanta. Please go ahead.Speaker4Thank you very much. Good morning, and welcome to Novanta's fourth quarter and full year 2025 earnings conference call. This is Ray Nash, Corporate Finance Leader for Novanta. With me on today's call is our Chair and Chief Executive Officer, Matthijs Gl ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-35083 NOVANTA INC. (Exact name of registrant as specified in its charter) New Brunswick, Canada 98-0110412 (State or other jurisdiction of incorpor ...

Exhibit 99.1 FOR IMMEDIATE RELEASE February 23, 2026 For the fourth quarter of 2025, Novanta generated GAAP revenue of $258.3 million, an increase of $20.3 million or 8.5%, compared to prior year. The Company's acquisition activities resulted in a net increase in revenue of $8.1 million or 3.4%. Year-over-year changes in foreign currency exchange rates favorably impacted revenue by $6.9 million or 2.9%. Organic Revenue Growth, which excludes the net impact of acquisitions and changes in foreign currency exc ...

Novanta Announces Financial Results for the Fourth Quarter and Full Year 2025-# Novanta Announces Financial Results for the Fourth Quarter and Full Year 2025Share---- Full Year 2025 Adjusted Diluted EPS was $3.29, and Adjusted EBITDA was $221 million- Full Year 2025 GAAP Revenue increased 3% to $981 million, and GAAP Diluted EPS was $1.47- Fourth Quarter 2025 Adjusted Diluted EPS was $0.91, increased 20%, and Adjusted EBITDA was $61 million, increased 17%- Fourth Quarter 2025 GAAP Revenue increased 9% to $2 ...

Core Insights - The CEO of Novanta, Matthijs Glastra, sold 6,500 shares as part of a Rule 10b5-1 trading plan, which is designed to prevent insider trading accusations [9] - The sale occurred at a time when Novanta's stock price has increased by approximately 23% year-to-date, reflecting strong business performance and demand for its products [10][11] Transaction Summary - The transaction involved the sale of 6,500 shares valued at approximately $878,458.68, based on a weighted average purchase price of $135.15 [2] - Post-transaction, the CEO holds 64,867 shares directly and 54,382 shares indirectly, with a total direct ownership value of around $8.7 million [2][6] Company Overview - Novanta specializes in photonics, vision, and precision motion solutions, primarily serving OEM customers in medical and industrial markets [7][8] - The company reported a total revenue of $960.31 million and a net income of $52.82 million for the trailing twelve months [4] Market Performance - The stock price of Novanta experienced a 1-year change of -3.37%, but has shown significant growth in early 2026 [4][10] - The company's bookings grew by 17% year-over-year, indicating strong demand and contributing to the rising stock price [11]

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Novanta (NOVT) . This company, which is in the Zacks Electronics - Miscellaneous Components industry, shows potential for another earnings beat.This photonic and motion control components maker has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an av ...